PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
89 hedge funds and large institutions have $226M invested in Poseida Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
31% more funds holding
Funds holding: 68 → 89 (+21)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
89
Holding in Top 10
2
Calls
$1.26M
Puts
$120K
Top Buyers
| 1 | +$7.92M | |
| 2 | +$3.06M | |
| 3 | +$2.71M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$1.93M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.82M |
Top Sellers
| 1 | -$3.71M | |
| 2 | -$2.65M | |
| 3 | -$1.72M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.67M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.06M |